PureTech Health PLC Stock Price Patterns
| PRTC Stock | USD 16.41 -0.23 -1.38% |
Momentum
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.615 | EPS Estimate Current Year -3.80 | EPS Estimate Next Year -2.30 | Wall Street Target Price 46 | Quarterly Revenue Growth 5.427 |
This section frames PureTech Health PLC response to recent headlines in a peer context.
This section maps attention patterns around PureTech Health and relates them to recent price behavior.
PureTech Health after-hype prediction price | $ 16.41 |
The hype panel supports comparisons with forecasting models, technical signals, analyst consensus, and earnings.
PureTech | Build portfolio with PureTech Stock |
The degree to which PureTech Health's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
After-Hype Price Density Analysis
The after-hype price distribution for PureTech Health helps investors understand how much of PureTech Health's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for PureTech Health are inherently more speculative.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical news patterns for PureTech Health reveal how the market has historically digested different types of information about PureTech Health's business and market environment. PureTech Health's after-hype downside and upside margins for the prediction period are 13.76 and 19.06, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
This after-hype projection for PureTech Health PLC uses a 3 months horizon to examine how price may behave after short-term sentiment effects dissipate. The practical value is that it frames how far price could retrace or stabilize once the headline cycle loses intensity.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as PureTech Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PureTech Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with PureTech Health, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.03 | 2.65 | 0.00 | 0.01 | 3 Events | 8 Events | In 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
16.41 | 16.41 | 0.00 |
|
Hype Timeline
PureTech Health PLC is at this time traded for 16.41. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. PureTech is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.03%. %. The volatility of related hype on PureTech Health is about 1055.78%, with the expected price after the next announcement by competition of 16.42. The company has price-to-book ratio of 1.07. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health PLC had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in 3 days. Cross-verify projections for PureTech Health using PureTech Health Basic Forecasting Models. The model set adds a statistical reference.Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of PureTech Health's competitive environment by quantifying the market's sensitivity to news across all major players in PureTech Health's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| AUTL | Autolus Therapeutics | -0.05 | 7 per month | 4.91 | 0.03 | 7.53 | -6.41 | 29.10 | |
| NGNE | Neurogene | 0.06 | 3 per month | 3.97 | 0.05 | 8.73 | -6.83 | 31.07 | |
| SLDB | Solid Biosciences LLC | -0.19 | 24 per month | 3.70 | 0.10 | 12.50 | -7.56 | 25.94 | |
| QSI | QuantumSi | -0.03 | 7 per month | 0.00 | -0.10 | 8.14 | -6.30 | 21.72 | |
| LCTX | Lineage Cell Therapeutics | 0.06 | 3 per month | 0.00 | 0.0038 | 4.65 | -5.64 | 21.47 | |
| BNTC | Benitec Biopharma Ltd | 0.16 | 8 per month | 0.00 | -0.02 | 5.86 | -6.53 | 15.86 | |
| ADCT | ADC Therapeutics SA | 0.30 | 6 per month | 3.38 | 0.09 | 7.56 | -5.41 | 24.46 | |
| ALMS | Alumis Inc | 1.96 | 9 per month | 3.49 | 0.14 | 9.22 | -7.19 | 103.99 | |
| RCKT | Rocket Pharmaceuticals | 0.31 | 9 per month | 2.93 | 0.15 | 9.29 | -4.96 | 22.29 | |
| NMRA | Neumora Therapeutics | -0.07 | 8 per month | 3.54 | 0.11 | 10.98 | -7.10 | 34.13 |
PureTech Health Additional Predictive Modules
Forecasting PureTech Health's price movement relies on structured analysis of indicator behavior, momentum signatures, and historical volatility patterns. Time-series models tend to perform better when fed clean, stationary data with consistent periodicity.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sentiment Indicators & Methodology
Sentiment analysis for PureTech Health evaluates news tone, positioning, and narrative momentum. Narrative divergence can signal instability and regime transition risk. PureTech Health has a market cap of 402.37 M, ROE of 9.44%.
Unless otherwise specified, data for PureTech Health PLC is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Popular Tools for PureTech Stock analysis
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |